332 related articles for article (PubMed ID: 21596626)
1. Antipsychotic use and the risk of diabetes in nursing home residents with dementia.
Jalbert JJ; Daiello LA; Eaton CB; Miller SC; Lapane KL
Am J Geriatr Pharmacother; 2011 Jun; 9(3):153-63. PubMed ID: 21596626
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia.
Jalbert JJ; Eaton CB; Miller SC; Lapane KL
J Am Med Dir Assoc; 2010 Feb; 11(2):120-7. PubMed ID: 20142067
[TBL] [Abstract][Full Text] [Related]
3. Why and how antipsychotic drugs are used in 40 Sydney nursing homes.
Snowdon J; Day S; Baker W
Int J Geriatr Psychiatry; 2005 Dec; 20(12):1146-52. PubMed ID: 16315158
[TBL] [Abstract][Full Text] [Related]
4. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
[TBL] [Abstract][Full Text] [Related]
5. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
[TBL] [Abstract][Full Text] [Related]
6. Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents.
Aparasu RR; Chatterjee S; Mehta S; Chen H
Med Care; 2012 Nov; 50(11):961-9. PubMed ID: 23047786
[TBL] [Abstract][Full Text] [Related]
7. Variation in antipsychotic treatment choice across US nursing homes.
Huybrechts KF; Rothman KJ; Brookhart MA; Silliman RA; Crystal S; Gerhard T; Schneeweiss S
J Clin Psychopharmacol; 2012 Feb; 32(1):11-7. PubMed ID: 22198446
[TBL] [Abstract][Full Text] [Related]
8. Risk of pneumonia in elderly nursing home residents using typical versus atypical antipsychotics.
Aparasu RR; Chatterjee S; Chen H
Ann Pharmacother; 2013 Apr; 47(4):464-74. PubMed ID: 23548651
[TBL] [Abstract][Full Text] [Related]
9. An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses.
Phillips LJ; Birtley NM; Petroski GF; Siem C; Rantz M
J Psychiatr Ment Health Nurs; 2018 Oct; 25(8):463-474. PubMed ID: 29911331
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic drug use among elderly nursing home residents in the United States.
Kamble P; Chen H; Sherer J; Aparasu RR
Am J Geriatr Pharmacother; 2008 Oct; 6(4):187-97. PubMed ID: 19028374
[TBL] [Abstract][Full Text] [Related]
11. New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder.
Erickson SC; Le L; Zakharyan A; Stockl KM; Harada AS; Borson S; Ramsey SD; Curtis B
J Am Geriatr Soc; 2012 Mar; 60(3):474-9. PubMed ID: 22288652
[TBL] [Abstract][Full Text] [Related]
12. The association between medications and falls in Australian nursing-home residents.
Yip YB; Cumming RG
Med J Aust; 1994 Jan; 160(1):14-8. PubMed ID: 7903790
[TBL] [Abstract][Full Text] [Related]
13. Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
Wang PS; Schneeweiss S; Avorn J; Fischer MA; Mogun H; Solomon DH; Brookhart MA
N Engl J Med; 2005 Dec; 353(22):2335-41. PubMed ID: 16319382
[TBL] [Abstract][Full Text] [Related]
14. Dying with advanced dementia in the nursing home.
Mitchell SL; Kiely DK; Hamel MB
Arch Intern Med; 2004 Feb; 164(3):321-6. PubMed ID: 14769629
[TBL] [Abstract][Full Text] [Related]
15. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.
Morrato EH; Druss B; Hartung DM; Valuck RJ; Allen R; Campagna E; Newcomer JW
Arch Gen Psychiatry; 2010 Jan; 67(1):17-24. PubMed ID: 20048219
[TBL] [Abstract][Full Text] [Related]
16. Use of antipsychotics among nonagenarian residents in long-term institutional care in Finland.
Alanen HM; Finne-Soveri H; Noro A; Leinonen E
Age Ageing; 2006 Sep; 35(5):508-13. PubMed ID: 16807310
[TBL] [Abstract][Full Text] [Related]
17. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.
Ray WA; Taylor JA; Meador KG; Lichtenstein MJ; Griffin MR; Fought R; Adams ML; Blazer DG
Arch Intern Med; 1993 Mar; 153(6):713-21. PubMed ID: 8447709
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in Antipsychotic and Benzodiazepine Prescribing Patterns: A Cohort Study of Newly Admitted Nursing Home Residents with Dementia in Ontario, Canada.
Maclagan LC; Maxwell CJ; Harris DA; Campitelli MA; Diong C; Lapane KL; Hogan DB; Rochon P; Herrmann N; Bronskill SE
Drugs Aging; 2020 Nov; 37(11):817-827. PubMed ID: 32978758
[TBL] [Abstract][Full Text] [Related]
19. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.
Kamble P; Chen H; Sherer JT; Aparasu RR
Drugs Aging; 2009; 26(6):483-92. PubMed ID: 19591523
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.
Dwyer LL; Han B; Woodwell DA; Rechtsteiner EA
Am J Geriatr Pharmacother; 2010 Feb; 8(1):63-72. PubMed ID: 20226393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
